BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34336878)

  • 1. Chronic Kidney Allograft Disease: New Concepts and Opportunities.
    Codina S; Manonelles A; Tormo M; Sola A; Cruzado JM
    Front Med (Lausanne); 2021; 8():660334. PubMed ID: 34336878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
    Höcker B; Tönshoff B
    Paediatr Drugs; 2009; 11(6):381-96. PubMed ID: 19877724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations.
    Chapman JR
    Kidney Int Suppl; 2005 Dec; (99):S108-12. PubMed ID: 16336561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies.
    Sotomayor CG; Giubergia F; Groothof D; Ferreccio C; Nolte IM; Navis GJ; Gomes-Neto AW; Kremer D; Knobbe TJ; Eisenga MF; Rodrigo R; Touw DJ; Bakker SJL;
    Am J Kidney Dis; 2022 Jul; 80(1):87-97.e1. PubMed ID: 34871698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
    Tantisattamo E; Leventhal JR; Mathew JM; Gallon L
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):63-74. PubMed ID: 33186221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal allograft dysfunction: risk factors, immunology and prevention.
    Fadili W; Habib Allah M; Laouad I
    Arab J Nephrol Transplant; 2013 Jan; 6(1):45-50. PubMed ID: 23282234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic allograft nephropathy.
    Fletcher JT; Nankivell BJ; Alexander SI
    Pediatr Nephrol; 2009 Aug; 24(8):1465-71. PubMed ID: 18584214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of late allograft loss in kidney transplantation.
    Cardarelli F; Saidman S; Theruvath T; Tolkoff-Rubin N; Cosimi AB; Pascual M
    Minerva Urol Nefrol; 2003 Mar; 55(1):1-11. PubMed ID: 12773962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors.
    Issa N; Kukla A; Ibrahim HN
    Arab J Urol; 2012 Jun; 10(2):169-74. PubMed ID: 26558021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and prevention of chronic kidney allograft loss.
    Nankivell BJ; Kuypers DR
    Lancet; 2011 Oct; 378(9800):1428-37. PubMed ID: 22000139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
    Wang CS; Gander J; Patzer RE; Greenbaum LA
    Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing renal transplant failure.
    Vathsala A
    Ann Acad Med Singap; 2005 Jan; 34(1):36-43. PubMed ID: 15726218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention.
    Irish A
    Am J Cardiovasc Drugs; 2004; 4(3):139-49. PubMed ID: 15134466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.